Legato Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $669K | Hold |
21,225
| – | – | 0.08% | 381 |
|
|
2025
Q1 | $695K | Sell |
21,225
-6,209
| -23% | -$203K | 0.09% | 348 |
|
|
2024
Q4 | $992K | Buy |
27,434
+5,962
| +28% | +$216K | 0.13% | 299 |
|
|
2024
Q3 | $669K | Hold |
21,472
| – | – | 0.08% | 384 |
|
|
2024
Q2 | $574K | Sell |
21,472
-5,933
| -22% | -$159K | 0.08% | 407 |
|
|
2024
Q1 | $935K | Buy |
27,405
+5,933
| +28% | +$202K | 0.11% | 282 |
|
|
2023
Q4 | $621K | Hold |
21,472
| – | – | 0.08% | 367 |
|
|
2023
Q3 | $592K | Sell |
21,472
-837
| -4% | -$23.1K | 0.09% | 359 |
|
|
2023
Q2 | $671K | Hold |
22,309
| – | – | 0.09% | 354 |
|
|
2023
Q1 | $808K | Hold |
22,309
| – | – | 0.15% | 239 |
|
|
2022
Q4 | $796K | Buy |
+22,309
| New | +$796K | 0.15% | 231 |
|
|
2018
Q1 | – | Sell |
-21,344
| Closed | -$851K | – | 208 |
|
|
2017
Q4 | $851K | Hold |
21,344
| – | – | 0.12% | 159 |
|
|
2017
Q3 | $854K | Hold |
21,344
| – | – | 0.13% | 161 |
|
|
2017
Q2 | $920K | Buy |
21,344
+19,185
| +889% | +$827K | 0.39% | 71 |
|
|
2017
Q1 | $68K | Hold |
2,159
| – | – | 0.08% | 47 |
|
|
2016
Q4 | $54.5K | Buy |
+2,159
| New | +$54.5K | 0.99% | 46 |
|